← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2012Last known activity
Sep 1, 2013
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT02104830Overall official - principal investigatorPhase 3Sep 1, 2013
- NCT01769950Lead sponsorN/AJan 31, 2013
- NCT01769950Reponsible party - principal investigatorN/AJan 31, 2013
- NCT01769950Sponsor investigatorN/AJan 31, 2013
- NCT01766323Study chairPhase 3Sep 1, 2012
Details
- Last known activity
- Sep 1, 2013